The Framingham risk score underestimates the risk of cardiovascular events in the HER2-positive breast cancer population
Law, W., Johnson, C., Rushton, M., Dent, S.Volume:
24
Language:
english
Journal:
Current Oncology
DOI:
10.3747/co.24.3684
Date:
October, 2017
File:
PDF, 386 KB
english, 2017